retatrutide glp-1 medication Latest Study Released:: People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says, The results — the most weight loss ever seen in a trial — put the New GLP-1 obesity drug, retatrutide,

They sit right in the ventral tegmental area (VTA) and nucleus accumbens, the same regions that light up when you experience joy, connection, excitement, and yes the pull toward food

There are a few GLP-1s being marketed exclusively as anti-obesity medications

Tirzepatide is the proven, accessible, well-characterized option that delivers exceptional results for most people

The 2026 American Diabetes Association Standards of Care recommend combining attention to protein intake with resistance training when preserving lean mass during weight-loss treatment

If considering the use of a GLP-1, set realistic expectations and maximize their effectiveness with these tips: Medications like semaglutide or tirzepatide deliver clinically meaningful weight loss over time

Track any mood changes or anxiety symptoms